Healthcare -
Biotechnology - NASDAQ - US
$ 0.7556
-7.85 %
$ 4.11 M
Market Cap
-0.01
P/E
ALZN - TOTAL CURRENT LIABILITIES
Total Current Liabilities ALZN - Alzamend Neuro, Inc.
3.23 M
LAST VALUE
66.41%
2 YEAR CAGR
22.20%
5 YEAR CAGR
0.00%
10 YEAR CAGR